docruДоктор.РуTitle1727-23782713-2994ООО "ГК "РУСМЕДИКАЛ"10.31550/1727-2378-2023-22-8-23-28docru-230Research ArticleКАРДИОМЕТАБОЛИЧЕСКАЯ МЕДИЦИНАCARDIOMETABOLIC MEDICINEФибрилляция предсердий и инфаркт миокарда: клинико-патогенетические взаимосвязи и влияние на прогнозAtrial Fibrillation and Myocardial Infarction: Clinical and Pathogenic Correlations and Impact for the Prognosishttps://orcid.org/0000-0001-6965-7869ШишкинаЕ. А.ShishkinaE. A.

Шишкина Екатерина Андреевна - д. м. н., доцент кафедры госпитальной терапии и кардиологии

614000, г. Пермь, ул. Петропавловская, д. 26

26 Petropavlovskaya St., Perm, 614000

doctor.shishkina@yandex.ruhttps://orcid.org/0000-0003-4860-0112ХлыноваО. В.KhlynovaO. V.

Хлынова Ольга Витальевна - член-корр. РАН, д. м. н., профессор, заведующая кафедрой госпитальной терапии и кардиологии

614000, г. Пермь, ул. Петропавловская, д. 26

26 Petropavlovskaya St., Perm, 614000

olgakhlynova@mail.ruhttps://orcid.org/0000-0002-3512-2214ЛебедеваЮ. И.LebedevaYu. I.

Лебедева Юлия Игоревна - к. м. н., ассистент кафедры госпитальной терапии и кардиологии

614000, г. Пермь, ул. Петропавловская, д. 26

26 Petropavlovskaya St., Perm, 614000

Lebedevapsmu@mail.ruhttps://orcid.org/0009-0007-5352-0666СафаровЭ. Н.SafarovE. N.

Сафаров Эльман Нурали Оглы - ординатор кафедры госпитальной терапии и кардиологии

614000, г. Пермь, ул. Петропавловская, д. 26

26 Petropavlovskaya St., Perm, 614000

safarov.elman@gmail.comhttps://orcid.org/0009-0007-5257-083XНаумоваН. А.NaumovaN. A.

Наумова Наталья Алексеевна - врач-кардиолог

614013, г. Пермь, ул. Маршала Жукова, д. 35

35 Marshala Zhukova St., Perm, 614013

sweet-rok@rambler.ruФГБОУ ВО «Пермский государственный медицинский университет имени академика Е.А. Вагнера» Министерства здравоохранения Российской ФедерацииРоссияE.A. Vagner Perm State Medical UniversityRussian FederationФГБУ «Федеральный центр сердечно-сосудистой хирургии имени С.Г. Суханова» Министерства здравоохранения Российской ФедерацииРоссияS.G. Sukhanov Federal Centre for Cardiovascular SurgeryRussian Federation202318022025228КАРДИОМЕТАБОЛИЧЕСКАЯ МЕДИЦИНА2328Copyright © Шишкина Е.А., Хлынова О.В., Лебедева Ю.И., Сафаров Э.Н., Наумова Н.А., 20252025Шишкина Е.А., Хлынова О.В., Лебедева Ю.И., Сафаров Э.Н., Наумова Н.А.Shishkina E.A., Khlynova O.V., Lebedeva Y.I., Safarov E.N., Naumova N.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://docru.elpub.ru/jour/article/view/230

Цель обзора. Обобщить современные литературные данные, касающиеся клинико-патогенетических взаимосвязей фибрилляции предсердий (ФП) и инфаркта миокарда (ИМ).Основные положения. ФП остается одной из наиболее часто встречающихся и клинически значимых аритмий. У пациентов с ИМ данный вид нарушений ритма регистрируется впервые с частотой от 6 до 21%. В обзоре освещены вопросы распространенности ФП у больных различными формами ишемической болезни сердца, механизмы аритмогенеза, а также обсуждаются способы прогнозирования неблагоприятных событий в когорте пациентов с ФП, перенесших ИМ.Заключение. Существует необходимость более детального понимания механизмов возникновения ФП у больных с ИМ. Требуется дальнейшее изучение влияния ФП на ближайший и отдаленный прогноз у пациентов с ИМ с созданием современных инструментов стратификации риска развития неблагоприятных событий.

Aim. To summarize the contemporary literature data on the clinical and pathogenic correlations between atrial fibrillation (AF) and myocardial infarction (MI).Key points. AF is one of the most common and clinically significant arrhythmias. In patients with MI, this type of arrhythmia is recorded for the first time in 6 % to 21 % of cases. The review discusses the incidence of AF in patients with various forms of coronary heart disease, mechanisms of arrhythmogenesis, and the ways to predict poor outcomes in a group of patients with AF who had a history of MI.Conclusion. The mechanisms of AF development in patients with MI need better understanding. AF impact on the short-term and long-term prognosis for patients with MI should be studied better, and modern tools for the classification of poor outcome risks should be developed.

фибрилляция предсердийинфаркт миокардапрогностическая значимостьatrial fibrillationmyocardial infarctionpredictive significanceReferencesHindricks G., Potpara T., Dagres N., Arbelo E. at al.; ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur. Heart J. 2021;42(5):373–498. DOI: 10.1093/eurheartj/ehaa612Hindricks G., Potpara T., Dagres N., Arbelo E. at al.; ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur. Heart J. 2021;42(5):373–498. DOI: 10.1093/eurheartj/ehaa612Tsao C.W., Aday A.W., Almarzooq Z.I., Alonso A. et al. Heart disease and stroke statistics — 2022 update: a report from the American Heart Association. Circulation. 2022;145(8):e153–639. DOI: 10.1161/CIR.0000000000001052Tsao C.W., Aday A.W., Almarzooq Z.I., Alonso A. et al. Heart disease and stroke statistics — 2022 update: a report from the American Heart Association. Circulation. 2022;145(8):e153–639. DOI: 10.1161/CIR.0000000000001052Lippi G., Sanchis-Gomar F., Cervellin G. Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge. Int. J. Stroke. 2021;16(2):217–21. Epub. 2020 Jan. 19. DOI: 10.1177/1747493019897870Lippi G., Sanchis-Gomar F., Cervellin G. Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge. Int. J. Stroke. 2021;16(2):217–21. Epub. 2020 Jan. 19. DOI: 10.1177/1747493019897870Benjamin E.J., Muntner P., Alonso A., Bittencourt M.S. et al.; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics — 2019 update: a report from the American Heart Association. Circulation. 2019;139(10): e56–28. DOI: 10.1161/CIR.0000000000000659Benjamin E.J., Muntner P., Alonso A., Bittencourt M.S. et al.; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics — 2019 update: a report from the American Heart Association. Circulation. 2019;139(10): e56–28. DOI: 10.1161/CIR.0000000000000659Nielsen J.C., Lin Y.-J., de Oliveira Figueiredo M.J., Shamloo A.S. et al. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population. EP Europace. 2020;22(8):1147–8. DOI: 10.1093/europace/euaa065Nielsen J.C., Lin Y.-J., de Oliveira Figueiredo M.J., Shamloo A.S. et al. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population. EP Europace. 2020;22(8):1147–8. DOI: 10.1093/europace/euaa065Patil S., Gonuguntla K., Rojulpote C., Kumar M. et al. Prevalence and determinants of atrial fibrillation-associated in-hospital ischemic stroke in patients with acute myocardial infarction undergoing percutaneous coronary intervention. Am. J. Cardiol. 2021;144:1–7. Epub. 2020 Dec. 29. DOI: 10.1016/j.amjcard.2020.12.066Patil S., Gonuguntla K., Rojulpote C., Kumar M. et al. Prevalence and determinants of atrial fibrillation-associated in-hospital ischemic stroke in patients with acute myocardial infarction undergoing percutaneous coronary intervention. Am. J. Cardiol. 2021;144:1–7. Epub. 2020 Dec. 29. DOI: 10.1016/j.amjcard.2020.12.066Кобалава Ж.Д., Лазарев П.В. Риск развития коронарных осложнений при фибрилляции предсердий. Кардиология. 2020;60(1):43–52.Kobalava Z.D., Lazarev P.V. Risk of coronary events in atrial fibrillation. Kardiologiia. 2020;60(1):43–52. (in Russian). DOI: 10.18087/cardio.2020.1.n828Ардашев А.В., Беленков Ю.Н., Матюкевич М.Ч., Снежицкий В.А. Фибрилляция предсердий и смертность: прогностические факторы и терапевтические стратегии. Кардиология. 2021; 61(2):91–8.Ardashev A.V., Belenkov Yu.N., Matsiukevich M.Ch., Snezhitskiy V.A. Atrial fibrillation and mortality: prognostic factors and direction of prevention. Kardiologiia. 2021;61(2):91–8. (in Russian). DOI: 10.18087/cardio.2021.2.n1348Di Carlo A., Bellino L., Consoli D., Mori F. et al.; National Research Program: Progetto FAI. La Fibrillazione Atriale in Italia. Prevalence of atrial fibrillation in the Italian elderly population and projections from 2020 to 2060 for Italy and the European Union: the FAI Project. Europace. 2019;21(10):1468–75. DOI: 10.1093/europace/euz141Di Carlo A., Bellino L., Consoli D., Mori F. et al.; National Research Program: Progetto FAI. La Fibrillazione Atriale in Italia. Prevalence of atrial fibrillation in the Italian elderly population and projections from 2020 to 2060 for Italy and the European Union: the FAI Project. Europace. 2019;21(10):1468–75. DOI: 10.1093/europace/euz141Mertz V., Cottin Y., Bentounes S.A., Pastier-Debeaumarché J. et al. Prognosis of atrial fibrillation with or without comorbidities: analysis of younger adults from a nationwide database. J. Clin. Med. 2022;11(7):1981. DOI: 10.3390/jcm11071981Mertz V., Cottin Y., Bentounes S.A., Pastier-Debeaumarché J. et al. Prognosis of atrial fibrillation with or without comorbidities: analysis of younger adults from a nationwide database. J. Clin. Med. 2022;11(7):1981. DOI: 10.3390/jcm11071981Andersson T., Magnuson A., Bryngelsson I.-L., Frøbert O. et al. Allcause mortality in 272,186 patients hospitalized with incident atrial fibrillation 1995–2008: a Swedish nationwide long-term case-control study. Eur. Heart J. 2013;34(14):1061–7. DOI: 10.1093/eurheartj/ehs469Andersson T., Magnuson A., Bryngelsson I.-L., Frøbert O. et al. Allcause mortality in 272,186 patients hospitalized with incident atrial fibrillation 1995–2008: a Swedish nationwide long-term case-control study. Eur. Heart J. 2013;34(14):1061–7. DOI: 10.1093/eurheartj/ehs469Шляхто Е.В., Ежов А.В., Зенин С.А., Козиолова Н.А. и др. Клинический портрет пациента с фибрилляцией предсердий в Российской Федерации. Данные глобального регистра GLORIA AF. Российский кардиологический журнал. 2017;9(149):21–7.Shlyakhto E.V., Ezhov А.V., Zenin S.А., Koziolova N.А. et al. Clinical portrait of the atrial fibrillation patient in Russian Federation. Data from the global registry GLORIA AF. Russian Journal of Cardiology. 2017;9(149):21–7. (in Russian). DOI: 10.15829/1560-4071-2017-9-138-142Buchta P., Kalarus Z., Mizia-Stec K., Myrda K. et al. De novo and pre-existing atrial fibrillation in acute coronary syndromes: impact on prognosis and cardiovascular events in long-term follow-up. Eur. Heart J. Acute Cardiovasc. Care. 2021;10(10):1129–39. DOI: 10.1093/ehjacc/zuab091Buchta P., Kalarus Z., Mizia-Stec K., Myrda K. et al. De novo and pre-existing atrial fibrillation in acute coronary syndromes: impact on prognosis and cardiovascular events in long-term follow-up. Eur. Heart J. Acute Cardiovasc. Care. 2021;10(10):1129–39. DOI: 10.1093/ehjacc/zuab091Jani B.D., Nicholl B.I., McQueenie R., Connelly D.T. et al. Multimorbidity and co-morbidity in atrial fibrillation and effects on survival: findings from UK Biobank cohort. Europace. 2018;20(FI_3):f329–36. DOI: 10.1093/europace/eux322Jani B.D., Nicholl B.I., McQueenie R., Connelly D.T. et al. Multimorbidity and co-morbidity in atrial fibrillation and effects on survival: findings from UK Biobank cohort. Europace. 2018;20(FI_3):f329–36. DOI: 10.1093/europace/eux322Belkouche A., Yao H., Putot A., Chagué F. et al. The multifaceted interplay between atrial fibrillation and myocardial infarction: a review. J. Clin. Med. 2021;10(2):198. DOI: 10.3390/jcm10020198Belkouche A., Yao H., Putot A., Chagué F. et al. The multifaceted interplay between atrial fibrillation and myocardial infarction: a review. J. Clin. Med. 2021;10(2):198. DOI: 10.3390/jcm10020198Батурина О.А., Андреев Д.А., Ананичева Н.А., Гиляров М.Ю. и др. Распространенность фибрилляции предсердий при остром коронарном синдроме и особенности назначения пероральных антитромботических препаратов. Кардиология. 2019;59(1):40–8.Baturina O.A., Andreev D.A., Ananicheva N.A., Gilyarov M.Yu. et al. Prevalence of atrial fibrillation and use of oral antithrombotic therapy in patients with acute coronary syndrome. Kardiologiia. 2019;59(1):40–8. (in Russian)]. DOI: 10.18087/cardio.2019.1.10213Guenancia Ch., Toucas C., Fauchier L., Stamboul K. et al. High rate of recurrence at long-term follow-up after new-onset atrial fibrillation during acute myocardial infarction. Europace. 2018;20(12): e179–88. DOI: 10.1093/europace/euy168Guenancia Ch., Toucas C., Fauchier L., Stamboul K. et al. High rate of recurrence at long-term follow-up after new-onset atrial fibrillation during acute myocardial infarction. Europace. 2018;20(12): e179–88. DOI: 10.1093/europace/euy168Pokorney S.D., Navar A.M. In patients with MI, new-onset or existing AF increased risk for CV events at 90 days. Ann. Intern. Med. 2016;164(12):JC66. DOI: 10.7326/ACPJC-2016-164-12-066Pokorney S.D., Navar A.M. In patients with MI, new-onset or existing AF increased risk for CV events at 90 days. Ann. Intern. Med. 2016;164(12):JC66. DOI: 10.7326/ACPJC-2016-164-12-066Soliman E.Z., Lopez F., O'Neal W.T., Chen L.Y. et al. Atrial fibrillation and risk of ST-segment-elevation versus non-ST-segment-elevation myocardial infarction: the Atherosclerosis Risk in Communities (ARIC) study. Circulation. 2015;131(21):1843–50. DOI: 10.1161/CIRCULATIONAHA.114.014145Soliman E.Z., Lopez F., O'Neal W.T., Chen L.Y. et al. Atrial fibrillation and risk of ST-segment-elevation versus non-ST-segment-elevation myocardial infarction: the Atherosclerosis Risk in Communities (ARIC) study. Circulation. 2015;131(21):1843–50. DOI: 10.1161/CIRCULATIONAHA.114.014145Soliman E.Z., Safford M.M., Muntner P., Khodneva Yu. et al. Atrial fibrillation and the risk of myocardial infarction. JAMA Intern. Med. 2014;174(1):107–14. DOI: 10.1001/jamainternmed.2013.11912Soliman E.Z., Safford M.M., Muntner P., Khodneva Yu. et al. Atrial fibrillation and the risk of myocardial infarction. JAMA Intern. Med. 2014;174(1):107–14. DOI: 10.1001/jamainternmed.2013.11912Liang F., Wang Y. Coronary heart disease and atrial fibrillation: a vicious cycle. Am. J. Physiol. Heart Circ. Physiol. 2021;320(1): H1–12. Epub. 2020 Nov. 13. DOI: 10.1152/ajpheart.00702.2020Liang F., Wang Y. Coronary heart disease and atrial fibrillation: a vicious cycle. Am. J. Physiol. Heart Circ. Physiol. 2021;320(1): H1–12. Epub. 2020 Nov. 13. DOI: 10.1152/ajpheart.00702.2020Börschel C.S., Schnabel R.B. The imminent epidemic of atrial fibrillation and its concomitant diseases — Myocardial infarction and heart failure — A cause for concern. Int. J. Cardiol. 2019:287: 162–73. Epub. 2018 Nov. 30. DOI: 10.1016/j.ijcard.2018.11.123Börschel C.S., Schnabel R.B. The imminent epidemic of atrial fibrillation and its concomitant diseases — Myocardial infarction and heart failure — A cause for concern. Int. J. Cardiol. 2019:287: 162–73. Epub. 2018 Nov. 30. DOI: 10.1016/j.ijcard.2018.11.123Putot A., Monin A., Belkouche A., Chagué F. et al. Preexisting atrial fibrillation and myocardial infarction: only 10% of infarcts directly linked to atrial fibrillation. Cardiovasc. Endocrinol. Metab. 2022;11(3):e0267. DOI: 10.1097/XCE.0000000000000267Putot A., Monin A., Belkouche A., Chagué F. et al. Preexisting atrial fibrillation and myocardial infarction: only 10% of infarcts directly linked to atrial fibrillation. Cardiovasc. Endocrinol. Metab. 2022;11(3):e0267. DOI: 10.1097/XCE.0000000000000267Shiyovich A., Axelrod M., Gilutz H., Plakht Y. Early versus late newonset atrial fibrillation in acute myocardial infarction: differences in clinical characteristics and predictors. Angiology. 2019;70(10): 921–8. DOI: 10.1177/0003319719867542Shiyovich A., Axelrod M., Gilutz H., Plakht Y. Early versus late newonset atrial fibrillation in acute myocardial infarction: differences in clinical characteristics and predictors. Angiology. 2019;70(10): 921–8. DOI: 10.1177/0003319719867542Batra G., Svennblad B., Held C., Jernberg T. et al. All types of atrial fibrillation in the setting of myocardial infarction are associated with impaired outcome. Heart. 2016;102(12):926–33. DOI: 10.1136/heartjnl-2015-308678Batra G., Svennblad B., Held C., Jernberg T. et al. All types of atrial fibrillation in the setting of myocardial infarction are associated with impaired outcome. Heart. 2016;102(12):926–33. DOI: 10.1136/heartjnl-2015-308678Maagh P., Butz T., Wickenbrock I., Prull M.W. et al. New-onset versus chronic atrial fibrillation in acute myocardial infarction: differences in short- and long-term follow-up. Clin. Res. Cardiol. 2011;100(2): 167–75. Epub. 2010 Sep. 23. DOI: 10.1007/s00392-010-0227-6Maagh P., Butz T., Wickenbrock I., Prull M.W. et al. New-onset versus chronic atrial fibrillation in acute myocardial infarction: differences in short- and long-term follow-up. Clin. Res. Cardiol. 2011;100(2): 167–75. Epub. 2010 Sep. 23. DOI: 10.1007/s00392-010-0227-6Dai Y., Yang J., Gao Z., Xu H. et al.; CAMI Registry study group. Atrial fibrillation in patients hospitalized with acute myocardial infarction: analysis of the china acute myocardial infarction (CAMI) registry. BMC Cardiovasc. Disord. 2017;17(1):2. DOI: 10.1186/s12872-016-0442-9Dai Y., Yang J., Gao Z., Xu H. et al.; CAMI Registry study group. Atrial fibrillation in patients hospitalized with acute myocardial infarction: analysis of the china acute myocardial infarction (CAMI) registry. BMC Cardiovasc. Disord. 2017;17(1):2. DOI: 10.1186/s12872-016-0442-9Kornej J., Henger S., Seewöster T., Teren A. et al. Prevalence of atrial fibrillation dependent on coronary artery status: insights from the LIFE-Heart study. Clin. Cardiol. 2020;43(12):1616–23. DOI: 10.1002/clc.23490Kornej J., Henger S., Seewöster T., Teren A. et al. Prevalence of atrial fibrillation dependent on coronary artery status: insights from the LIFE-Heart study. Clin. Cardiol. 2020;43(12):1616–23. DOI: 10.1002/clc.23490El-Shetry M., Mahfouz R., Frere A.-F., Abdeldayem M. The interplay between atrial fibrillation and acute myocardial infarction. Br. J. Hosp. Med. (Lond.). 2021;82(2):1–9. DOI: 10.12968/hmed.2020.0584El-Shetry M., Mahfouz R., Frere A.-F., Abdeldayem M. The interplay between atrial fibrillation and acute myocardial infarction. Br. J. Hosp. Med. (Lond.). 2021;82(2):1–9. DOI: 10.12968/hmed.2020.0584He J., Yang Y., Zhang G., Lu X.-H. Clinical risk factors for new-onset atrial fibrillation in acute myocardial infarction: a systematic review and meta-analysis. Medicine (Baltimore). 2019;98(26):e15960. DOI: 10.1097/MD.0000000000015960He J., Yang Y., Zhang G., Lu X.-H. Clinical risk factors for new-onset atrial fibrillation in acute myocardial infarction: a systematic review and meta-analysis. Medicine (Baltimore). 2019;98(26):e15960. DOI: 10.1097/MD.0000000000015960Pizzetti F., Turazza F.M., Franzosi M.G., Barlera S. et al.; GISSI-3 Investigators. Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data. Heart. 2001;86(5):527–32. DOI: 10.1136/heart.86.5.527Pizzetti F., Turazza F.M., Franzosi M.G., Barlera S. et al.; GISSI-3 Investigators. Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data. Heart. 2001;86(5):527–32. DOI: 10.1136/heart.86.5.527Vermond R.A., Van Gelder I.C., Crijns H.J., Rienstra M. Does myocardial infarction beget atrial fibrillation and atrial fibrillation beget myocardial infarction? Circulation. 2015;131(21):1824–6. DOI: 10.1161/CIRCULATIONAHA.115.016595Vermond R.A., Van Gelder I.C., Crijns H.J., Rienstra M. Does myocardial infarction beget atrial fibrillation and atrial fibrillation beget myocardial infarction? Circulation. 2015;131(21):1824–6. DOI: 10.1161/CIRCULATIONAHA.115.016595Sinno H., Derakhchan K., Libersan D., Merhi Y. et al. Atrial ischemia promotes atrial fibrillation in dogs. Circulation. 2003;107(14): 1930–6. DOI: 10.1161/01.CIR.0000058743.15215.03Sinno H., Derakhchan K., Libersan D., Merhi Y. et al. Atrial ischemia promotes atrial fibrillation in dogs. Circulation. 2003;107(14): 1930–6. DOI: 10.1161/01.CIR.0000058743.15215.03Broch K., Anstensrud A.K., Woxholt S., Sharma K. et al. Randomized trial of Interleukin-6 receptor inhibition in patients with acute ST-segment elevation myocardial infarction. J. Am. Coll. Cardiol. 2021;77(15): 1845–55. DOI: 10.1016/j.jacc.2021.02.049Broch K., Anstensrud A.K., Woxholt S., Sharma K. et al. Randomized trial of Interleukin-6 receptor inhibition in patients with acute ST-segment elevation myocardial infarction. J. Am. Coll. Cardiol. 2021;77(15): 1845–55. DOI: 10.1016/j.jacc.2021.02.049Cheng W.-L., Chen Y.-C., Li S.-J., Lee T.-I. et al. Galectin-3 enhances atrial remodelling and arrhythmogenesis through CD98 signalling. Acta Physiol. (Oxf.). 2022;234(3):e13784. DOI: 10.1111/apha.13784Cheng W.-L., Chen Y.-C., Li S.-J., Lee T.-I. et al. Galectin-3 enhances atrial remodelling and arrhythmogenesis through CD98 signalling. Acta Physiol. (Oxf.). 2022;234(3):e13784. DOI: 10.1111/apha.13784Martins G.L., Duarte R.C.F., Vieira É.L.M., Rocha N.P. et al. Evaluation of new potential inflammatory markers in patients with nonvalvular atrial fibrillation. Int. J. Mol. Sci. 2023;24(4):3326. DOI: 10.3390/ijms24043326Martins G.L., Duarte R.C.F., Vieira É.L.M., Rocha N.P. et al. Evaluation of new potential inflammatory markers in patients with nonvalvular atrial fibrillation. Int. J. Mol. Sci. 2023;24(4):3326. DOI: 10.3390/ijms24043326Hofer F., Kazem N., Hammer A., El-Hamid F. et al. Long-term prognosis of de novo atrial fibrillation during acute myocardial infarction: the impact of anti-thrombotic treatment strategies. Eur. Heart J. Cardiovasc. Pharmacother. 2021;7(3):189–95. DOI: 10.1093/ehjcvp/pvaa027Hofer F., Kazem N., Hammer A., El-Hamid F. et al. Long-term prognosis of de novo atrial fibrillation during acute myocardial infarction: the impact of anti-thrombotic treatment strategies. Eur. Heart J. Cardiovasc. Pharmacother. 2021;7(3):189–95. DOI: 10.1093/ehjcvp/pvaa027Соловьева М.В., Болдуева С.А. Прогностическое значение фибрилляции предсердий у больных, перенесших инфаркт миокарда. Результаты многолетнего наблюдения. Российский кардиологический журнал. 2021;26(2):4285.Solovieva M.V., Boldueva S.A. Prognostic value of atrial fibrillation in patients with myocardial infarction. Long-term follow-up results. Russian Journal of Cardiology. 2021;26(2):4285. (in Russian). DOI: 10.15829/1560-4071-2021-4285Бородашкина С.Ю., Протасов К.В. Клинико-патогенетические особенности инфаркта миокарда у больных фибрилляцией предсердий. Сибирское медицинское обозрение. 2020;5:31–9.Borodashkina S.Y., Protasov K.V. Clinical and pathogenetic features of myocardial infarction in patients with atrial fibrillation. Siberian Medical Review. 2020;5:31–9. (in Russian). DOI: 10.20333/2500136-2020-5-31-39Jabre P., Roger V.L., Murad M.H., Chamberlain A.M. et al. Mortality associated with atrial fibrillation in patients with myocardial infarction: a systematic review and metaanalysis. Circulation. 2011;123(15):1587–93. DOI: 10.1161/CIRCULATIONAHA.110.986661Jabre P., Roger V.L., Murad M.H., Chamberlain A.M. et al. Mortality associated with atrial fibrillation in patients with myocardial infarction: a systematic review and metaanalysis. Circulation. 2011;123(15):1587–93. DOI: 10.1161/CIRCULATIONAHA.110.986661Zeymer U., Annemans L., Danchin N., Pocock S. et al. Impact of known or new-onset atrial fibrillation on 2-year cardiovascular event rate in patients with acute coronary syndromes: results from the prospective EPICOR Registry. Eur. Heart J. Acute Cardiovasc. Care. 2019;8(2):121–9. Epub. 2018 Apr. 3. DOI: 10.1177/2048872618769057Zeymer U., Annemans L., Danchin N., Pocock S. et al. Impact of known or new-onset atrial fibrillation on 2-year cardiovascular event rate in patients with acute coronary syndromes: results from the prospective EPICOR Registry. Eur. Heart J. Acute Cardiovasc. Care. 2019;8(2):121–9. Epub. 2018 Apr. 3. DOI: 10.1177/2048872618769057Зыков М.В., Барбараш О.Л. Патогенетические и клинические аспекты фибрилляции предсердий при инфаркте миокарда. Российский кардиологический журнал. 2021;26(2):4307.Zykov M.V., Barbarash O.L. Pathogenetic and clinical aspects of atrial fibrillation in myocardial infarction. Russian Journal of Cardiology. 2021;26(2):4307. (in Russian). DOI: 10.15829/1560-4071-2021-4307Congo K.H., Belo A., Carvalho J., Neves D. et al. New-onset atrial fibrillation in ST-segment elevation myocardial infarction: predictors and impact on therapy and mortality. Arq. Bras. Cardiol. 2019;113(5): 948–57. DOI: 10.5935/abc.20190190Congo K.H., Belo A., Carvalho J., Neves D. et al. New-onset atrial fibrillation in ST-segment elevation myocardial infarction: predictors and impact on therapy and mortality. Arq. Bras. Cardiol. 2019;113(5): 948–57. DOI: 10.5935/abc.20190190Guo T., Xi Z., Qiu H., Wang Y. et al. Prognostic value of GRACE and CHA2DS2-VASc score among patients with atrial fibrillation undergoing percutaneous coronary intervention. Ann. Med. 2021;53(1):2215–24. DOI: 10.1080/07853890.2021.2004321Guo T., Xi Z., Qiu H., Wang Y. et al. Prognostic value of GRACE and CHA2DS2-VASc score among patients with atrial fibrillation undergoing percutaneous coronary intervention. Ann. Med. 2021;53(1):2215–24. DOI: 10.1080/07853890.2021.2004321Greco A., Capodanno D. Therapeutic uncertainties: first finding of atrial fibrillation in acute coronary syndrome. Eur. Heart J. Suppl. 2022;24(Suppl. I):I43–6. DOI: 10.1093/eurheartjsupp/suac072Greco A., Capodanno D. Therapeutic uncertainties: first finding of atrial fibrillation in acute coronary syndrome. Eur. Heart J. Suppl. 2022;24(Suppl. I):I43–6. DOI: 10.1093/eurheartjsupp/suac072Petersen J.K., Butt J.H., Yafasova A., Torp-Pedersen C. et al. Incidence of ischaemic stroke and mortality in patients with acute coronary syndrome and first-time detected atrial fibrillation: a nationwide study. Eur. Heart J. 2021;42(44):4553–61. DOI: 10.1093/eurheartj/ehab575Petersen J.K., Butt J.H., Yafasova A., Torp-Pedersen C. et al. Incidence of ischaemic stroke and mortality in patients with acute coronary syndrome and first-time detected atrial fibrillation: a nationwide study. Eur. Heart J. 2021;42(44):4553–61. DOI: 10.1093/eurheartj/ehab575Zeymer U., Annemans L., Danchin N., Pocock S. et al. Impact of known or new-onset atrial fibrillation on 2-year cardiovascular event rate in patients with acute coronary syndromes: results from the prospective EPICOR Registry. Eur. Heart J. Acute Cardiovasc. Care. 2019;8(2):121–9. Epub. 2018 Apr. 3. DOI: 10.1177/2048872618769057Zeymer U., Annemans L., Danchin N., Pocock S. et al. Impact of known or new-onset atrial fibrillation on 2-year cardiovascular event rate in patients with acute coronary syndromes: results from the prospective EPICOR Registry. Eur. Heart J. Acute Cardiovasc. Care. 2019;8(2):121–9. Epub. 2018 Apr. 3. DOI: 10.1177/2048872618769057Angeli F., Reboldi G., Garofoli M., Ramundo E. et al. Atrial fibrillation and mortality in patients with acute myocardial infarction: a systematic overview and meta-analysis. Curr. Cardiol. Rep. 2012;14(5):601–10. DOI: 10.1007/s11886-012-0289-3Angeli F., Reboldi G., Garofoli M., Ramundo E. et al. Atrial fibrillation and mortality in patients with acute myocardial infarction: a systematic overview and meta-analysis. Curr. Cardiol. Rep. 2012;14(5):601–10. DOI: 10.1007/s11886-012-0289-3Kundu A., O’Day K., Shaikh A.Y., Lessard D.M. et al. Relation of atrial fibrillation in acute myocardial infarction to in-hospital complications and early hospital readmission. Am. J. Cardiol. 2016;117(8):1213–8. DOI: 10.1016/j.amjcard.2016.01.012Kundu A., O’Day K., Shaikh A.Y., Lessard D.M. et al. Relation of atrial fibrillation in acute myocardial infarction to in-hospital complications and early hospital readmission. Am. J. Cardiol. 2016;117(8):1213–8. DOI: 10.1016/j.amjcard.2016.01.012Biasco L., Radovanovic D., Moccetti M., Rickli H. et al. New-onset or preexisting atrial fibrillation in acute coronary syndromes: two distinct phenomena with a similar prognosis. Rev. Esp. Cardiol. 2019;72(5): 383–91. Epub. 2018 Apr. 10. DOI: 10.1016/j.rec.2018.03.002Biasco L., Radovanovic D., Moccetti M., Rickli H. et al. New-onset or preexisting atrial fibrillation in acute coronary syndromes: two distinct phenomena with a similar prognosis. Rev. Esp. Cardiol. 2019;72(5): 383–91. Epub. 2018 Apr. 10. DOI: 10.1016/j.rec.2018.03.002

The authors declare that there are no conflicts of interest present.